Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.32 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15158116 | 0.95 | TSHR (0.37) | TSHRMEN1KMT2ALMNAHTT | |
| SCHEMBL66400 | 0.93 | TSHR (0.35) | TSHRMEN1KMT2ALMNAHTT | |
| SCHEMBL29771136 | 0.93 | TSHR (0.35) | TSHRMEN1KMT2ALMNAHTT | |
| SCHEMBL29114642 | 0.88 | MEN1 (0.36) | TSHRMEN1KMT2AHTTALDH1A1 | |
| SCHEMBL29771328 | 0.88 | MEN1 (0.36) | TSHRMEN1KMT2AHTTALDH1A1 | |
| SCHEMBL65695 | 0.88 | MEN1 (0.36) | TSHRMEN1KMT2AHTTALDH1A1 | |
| SCHEMBL392038 | 0.87 | MEN1 (0.34) | TSHRMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL32674605 | 0.86 | EGFR (0.33) | TSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6472692 | 0.86 | TSHR (0.36) | TSHRKMT2AHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL6292049 | 0.85 | THRB (0.42) | TSHRMEN1KMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992538-B2 | Polymerizable dental composition based on condensed silanes | VOCO GMBH (DE) | 2024-05-28 | — | — | US | claimed |
| EP-4306099-A1 | METHOD FOR PRODUCING DENTAL MILL BLANKS | VOCO GmbH (DE) | 2024-01-17 | — | — | EP | claimed |
| US-20240008963-A1 | PROCESS FOR THE PRODUCTION OF DENTAL MILLING BLANKS | VOCO GMBH (DE) | 2024-01-11 | — | — | US | claimed |
| US-20210052469-A1 | POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES | VOCO GMBH (DE) | 2021-02-25 | — | — | US | claimed |
| EP-2623087-B1 | Dental composite materials containing tricyclic plasticisers | VOCO GMBH (DE) | 2019-07-17 | — | — | EP | claimed |
| EP-2623086-B1 | Curable mixture comprising plasticisers with a polyalicyclic structure element for use in the production of dental materials. | VOCO GMBH (DE) | 2019-07-10 | — | — | EP | claimed |
| US-9314408-B2 | Dental composite materials comprising tricyclic plasticizers | VOCO GMBH (DE) | 2016-04-19 | — | — | US | claimed |
| US-20130203884-A1 | DENTAL COMPOSITE MATERIALS COMPRISING TRICYCLIC PLASTICIZERS | VOCO GMBH (DE) | 2013-08-08 | — | — | US | claimed |
| US-7799844-B2 | Active energy beam-curable composition for optical material | TOAGOSEI CO., LTD. (JP) | 2010-09-21 | — | — | US | claimed |
| EP-0735062-B1 | ACTINIC-RADIATION-CURABLE COMPOSITION AND LENS SHEET | MITSUBISHI RAYON CO (JP) | 2002-01-30 | — | — | EP | claimed |
| US-6206550-B1 | BACKLIGHT WITH LENS PORTION MADE FROM A CURABLE COMPOSITION WHICH INCLUDES A BIS(4-(METH)ACRYLOYL-THIOPHENYL) SULFIDE AND (METH)ACRYLATES; HIGH BRIGHTNESS-ENHANCING EFFECT ON LENSES OF PROJECTION TVS AND STEREOSCOPIC PHOTOGRAPHY. | MITSUBISHI RAYON COMPANY LTD. (JP) | 2001-03-27 | — | — | US | claimed |
| US-5969867-A | ACRYLIC ESTERS | MITSUBISHI RAYON COMPANY LTD. (JP) | 1999-10-19 | — | — | US | claimed |
| EP-0735062-A1 | ACTINIC-RADIATION-CURABLE COMPOSITION AND LENS SHEET | MITSUBISHI RAYON CO., LTD. (JP) | 1996-10-02 | — | — | EP | claimed |
| US-4647638-A | Novel organophosphate and adhesive comprising it | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1987-03-03 | — | — | US | claimed |
| EP-4725470-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20250032366-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2025-01-30 | — | — | US | disclosed |
| WO-2024253204-A1 | CURABLE DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2024-12-12 | — | — | WO | disclosed |
| US-4388421-A | PRIMERS | LION CORPORATION (JP) | 1983-06-14 | — | — | US | disclosed |
| US-4383052-A | 1-Methacryloxyethane-1,1-diphosphonic acid and its salts and dental adhesive composition containing same | LION CORPORATION (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4055542-A | PEROXIDE | THREE BOND CO., LTD. (JA) | 1977-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992538-B2 | Polymerizable dental composition based on condensed silanes | NCAPH, RCC1, NCAPD2 | TSHR 4596/4885MEN1 3233/4885KMT2A 628/4885 |
| US-20250032366-A1 | DENTAL CURABLE COMPOSITION | H1-0, COL1A1, CHAF1B | TSHR 4352/4885MEN1 353/4885KMT2A 2851/4885 |
| US-20130203884-A1 | DENTAL COMPOSITE MATERIALS COMPRISING TRICYCLIC PLASTICIZERS | CAD, PBRM1, PCBP1 | TSHR 3986/4885MEN1 3804/4885KMT2A 2690/4885 |
| US-20210052469-A1 | POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES | NCAPH, RCC1, NCAPD2 | TSHR 4596/4885MEN1 3233/4885KMT2A 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.